These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11207643

  • 1. Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism.
    Li Voon Chong JS, Sen J, Johnson Z, Kyle G, MacFarlane IA.
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):267-71. PubMed ID: 11207643
    [Abstract] [Full Text] [Related]

  • 2. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.
    DeVile CJ, Stanhope R.
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):37-41. PubMed ID: 9302370
    [Abstract] [Full Text] [Related]

  • 3. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M, Gryczyńska M, Sowińska A, Sowiński J.
    Przegl Lek; 2011 Jul; 68(2):96-102. PubMed ID: 21751518
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism.
    Dunne FP, Elliot P, Gammage MD, Stallard T, Ryan T, Sheppard MC, Stewart PM.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):623-9. PubMed ID: 8548948
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
    Ekman B, Bachrach-Lindström M, Lindström T, Wahlberg J, Blomgren J, Arnqvist HJ.
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP.
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
    [Abstract] [Full Text] [Related]

  • 7. Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy.
    Hangaard J, Andersen M, Grodum E, Koldkjaer O, Hagen C.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2502-7. PubMed ID: 8675567
    [Abstract] [Full Text] [Related]

  • 8. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S.
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [Abstract] [Full Text] [Related]

  • 9. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
    Ross IL, Levitt NS, Van der Walt JS, Schatz DA, Johannsson G, Haarburger DH, Pillay TS.
    Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
    [Abstract] [Full Text] [Related]

  • 10. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A, Liew A, Finucane F, Baker L, O'Kelly P, Tormey W, Thompson CJ.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [Abstract] [Full Text] [Related]

  • 11. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes.
    Riedel M, Wiese A, Schürmeyer TH, Brabant G.
    Exp Clin Endocrinol; 1993 Jun; 101(2):106-11. PubMed ID: 8405139
    [Abstract] [Full Text] [Related]

  • 12. Diurnal variation of intraocular pressure in normal and ocular hypertensive subjects of China.
    Xi XR, Qureshi IA, Wu XD, Huang YB, Lu H, Shiarkar E.
    J Pak Med Assoc; 1996 Aug; 46(8):171-4. PubMed ID: 8936973
    [Abstract] [Full Text] [Related]

  • 13. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
    Giordano R, Guaraldi F, Marinazzo E, Fumarola F, Rampino A, Berardelli R, Karamouzis I, Lucchiari M, Manetta T, Mengozzi G, Arvat E, Ghigo E.
    Endocrine; 2016 Feb; 51(2):360-8. PubMed ID: 26184416
    [Abstract] [Full Text] [Related]

  • 14. Seasonal and diurnal variations of ocular pressure in ocular hypertensive subjects in Pakistan.
    Qureshi IA, Xiao RX, Yang BH, Zhang J, Xiang DW, Hui JL.
    Singapore Med J; 1999 May; 40(5):345-8. PubMed ID: 10489493
    [Abstract] [Full Text] [Related]

  • 15. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.
    Verma S, Vanryzin C, Sinaii N, Kim MS, Nieman LK, Ravindran S, Calis KA, Arlt W, Ross RJ, Merke DP.
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):441-7. PubMed ID: 19486026
    [Abstract] [Full Text] [Related]

  • 16. Twenty-four-hour efficacy of preservative-free tafluprost for open-angle glaucoma patients, assessed by home intraocular pressure (Icare-ONE) and blood-pressure monitoring.
    Cho SY, Kim YY, Yoo C, Lee TE.
    Jpn J Ophthalmol; 2016 Jan; 60(1):27-34. PubMed ID: 26411460
    [Abstract] [Full Text] [Related]

  • 17. Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.
    Rácz P, Ruzsonyi MR, Nagy ZT, Gaygi Z, Bito LZ.
    Arch Ophthalmol; 1996 Mar; 114(3):268-73. PubMed ID: 8600885
    [Abstract] [Full Text] [Related]

  • 18. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-Price J, Tucker GT, Ross RJ.
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [Abstract] [Full Text] [Related]

  • 19. Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism.
    McConnell EM, Bell PM, Ennis C, Hadden DR, McCance DR, Sheridan B, Atkinson AB.
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):195-201. PubMed ID: 11874410
    [Abstract] [Full Text] [Related]

  • 20. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.
    Konstas AG, Tsironi S, Vakalis AN, Nasr MB, Stewart JA, Nelson LA, Stewart WC.
    Acta Ophthalmol; 2009 Feb; 87(1):71-6. PubMed ID: 19178390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.